effectiveness of group contracting and behavioral activation therapy on relapse prevention opioid substance use disorders

ABSTRACT

The objective of the present study was to examine the effectiveness of Group Contracting and Behavioral Activation Therapy [GCBAT] for treatment of opioid substance use disorders. In this clinical trial study, 120 patients suffering from opioid dependence enrolled in methadone maintenance treatment programs were assigned randomly in four groups including., Cognitive-Behavioral Therapy [CBT]., group A, Group Contracting and Behavioral Activation Therapy [GCBAT]., group B, Group Contracting and Behavioral Activation Therapy plus family support education [GCBAT- FSE]., group C, and group D received only treatment of methadone. Two experimental groups [B and C] received 8 weekly sessions group therapy. Group [A] took 12 weekly sessions group therapy and group D took methadone only. All participants 5 months later followup Outcome data were analyzed with using chi-square test. Results revealed that three experimental groups had more effectiveness than methadone alone, GCBAT and CBT in relapse prevention. Patients in relapse prevention and remaining on treatment follow up their experience of a relapse group C were superior from patients in groups A, B and D